Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 19395984)

1.

Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease.

Alexander TH, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ, Hammerschlag PE, Hannley M, Hughes GB, Moscicki R, Nelson RA, Niparko JK, Rauch SD, Telian SA, Brookhouser PE, Harris JP.

Otol Neurotol. 2009 Jun;30(4):443-8. doi: 10.1097/MAO.0b013e3181a52773.

PMID:
19395984
2.

Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.

Harris JP, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ, Hammerschlag PE, Hannley M, Hughes GB, Moscicki R, Nelson RA, Niparko JK, Rauch SD, Telian SA, Brookhouser PE.

JAMA. 2003 Oct 8;290(14):1875-83.

PMID:
14532316
3.

Autoimmune inner ear disease.

Ruckenstein MJ.

Curr Opin Otolaryngol Head Neck Surg. 2004 Oct;12(5):426-30. Review.

PMID:
15377956
4.

Immune-mediated inner ear disease: 10-year experience.

Broughton SS, Meyerhoff WE, Cohen SB.

Semin Arthritis Rheum. 2004 Oct;34(2):544-8.

PMID:
15505770
5.

Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.

Jover JA, Hernández-García C, Morado IC, Vargas E, Bañares A, Fernández-Gutiérrez B.

Ann Intern Med. 2001 Jan 16;134(2):106-14.

PMID:
11177313
6.

Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial.

Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, Goebel JA, Hammerschlag PE, Harris JP, Isaacson B, Lee D, Linstrom CJ, Parnes LS, Shi H, Slattery WH, Telian SA, Vrabec JT, Reda DJ.

JAMA. 2011 May 25;305(20):2071-9. doi: 10.1001/jama.2011.679.

PMID:
21610239
7.

A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).

Spiera RF, Mitnick HJ, Kupersmith M, Richmond M, Spiera H, Peterson MG, Paget SA.

Clin Exp Rheumatol. 2001 Sep-Oct;19(5):495-501.

PMID:
11579707
8.

Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.

Van Wijk F, Staecker H, Keithley E, Lefebvre PP.

Audiol Neurootol. 2006;11(6):357-65. Epub 2006 Sep 21.

PMID:
16988499
9.

A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial.

Bernstein IL, Bernstein DI, Dubb JW, Faiferman I, Wallin B.

J Allergy Clin Immunol. 1996 Aug;98(2):317-24.

PMID:
8757209
10.

Autoimmune inner ear disease preliminary case report: audiometric findings following steroid treatments.

Harris DA, Mikulec AA, Carls SL.

Am J Audiol. 2013 Jun;22(1):120-4. doi: 10.1044/1059-0889(2012/12-0040).

PMID:
23800807
11.

Immunosuppressive therapy for autoimmune inner ear disease.

Buniel MC, Geelan-Hansen K, Weber PC, Tuohy VK.

Immunotherapy. 2009 May;1(3):425-34. Review.

12.

Early efficacy trial of anakinra in corticosteroid-resistant autoimmune inner ear disease.

Vambutas A, Lesser M, Mullooly V, Pathak S, Zahtz G, Rosen L, Goldofsky E.

J Clin Invest. 2014 Sep;124(9):4115-22. doi: 10.1172/JCI76503. Epub 2014 Aug 18.

13.

Serial audiometry in a clinical trial of AIED treatment.

Niparko JK, Wang NY, Rauch SD, Russell GB, Espeland MA, Pierce JJ, Bowditch S, Masuda A, Gulya AJ, Gantz BJ, Hughes GB, Brookhouser PE, Hannley MT, Telian SA, Harris JP; AIED Study Group.

Otol Neurotol. 2005 Sep;26(5):908-17.

PMID:
16151337
14.

Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study.

Cohen S, Shoup A, Weisman MH, Harris J.

Otol Neurotol. 2005 Sep;26(5):903-7.

PMID:
16151336
15.

Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.

Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, Younge BR, Weyand CM, Goronzy JJ.

Arthritis Rheum. 2006 Oct;54(10):3310-8.

16.

Methotrexate for induction of remission in refractory Crohn's disease.

McDonald JW, Wang Y, Tsoulis DJ, MacDonald JK, Feagan BG.

Cochrane Database Syst Rev. 2014 Aug 6;8:CD003459. doi: 10.1002/14651858.CD003459.pub4. Review.

PMID:
25099640
17.

Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study.

Mullarkey MF, Blumenstein BA, Andrade WP, Bailey GA, Olason I, Wetzel CE.

N Engl J Med. 1988 Mar 10;318(10):603-7.

PMID:
3278232
18.

Methotrexate for induction of remission in refractory Crohn's disease.

McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD003459. doi: 10.1002/14651858.CD003459.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;8:CD003459.

PMID:
23235598
19.

The utility of positron emission tomography in the evaluation of autoimmune hearing loss.

Mazlumzadeh M, Lowe VJ, Mullan BP, Fabry DA, McDonald TJ, Matteson EL.

Otol Neurotol. 2003 Mar;24(2):201-4.

PMID:
12621332
20.

An open label study to evaluate the safety and efficacy of intratympanic golimumab therapy in patients with autoimmune inner ear disease.

Derebery MJ, Fisher LM, Voelker CC, Calzada A.

Otol Neurotol. 2014 Oct;35(9):1515-21. doi: 10.1097/MAO.0000000000000566.

PMID:
25203561
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk